DJIA 16,351.38 293.03 1.82%
NASDAQ 4,749.98 113.87 2.46%
S&P 500 1,948.86 35.01 1.83%
market minute promo

Endocyte, Inc. (NASDAQ: ECYT)

5.30 0.16 (3.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ECYT $5.30 3.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.18
Previous Close $5.14
Daily Range $5.04 - $5.30
52-Week Range $4.61 - $9.35
Market Cap $222.5M
P/E Ratio -6.05
Dividend (Yield) $0.00 (0.0%)
Volume 259,609
Average Daily Volume 303,724
Current FY EPS -$1.06

Sector

Healthcare

Industry

Drug Makers

Endocyte, Inc. (ECYT) Description

Endocyte Inc is a biopharmaceutical Company developing targeted therapies for the treatment of cancer and inflammatory diseases. It uses its proprietary technology to create novel small molecule drug conjugates or SMDCs and companion imaging diagnose. Website: http://www.endocyte.com/

News & Commentary

3 Biotech Stocks to Buy in August

Biotech stocks have crushed the broader market in recent years. Here are three our healthcare analysts are eyeing in August.

New Strong Buy Stocks for August 12th

Endocyte (ECYT) Posts Narrower-than-Expected Loss in Q2 - Analyst Blog

Endocyte's (ECYT) CEO Ron Ellis on Q2 2015 Results - Earnings Call Transcript

Will Endocyte (ECYT) Earnings Surprise Investors in Q2? - Analyst Blog

Will Endocyte (ECYT) Earnings Surprise Investors in Q2? - Analyst Blog

Biotech Weekly: Top Value Biotech Picks Starting Q3 2015

Endocyte: A Promising Prospect In The Oncology Space

Endocyte's (ECYT) CEO on Q1 2015 Results - Earnings Call Transcript

Mallinckrodt Tops Q2 Earnings & Revenues on Acquisitions - Analyst Blog

Mallinckrodt Tops Q2 Earnings & Revenues on Acquisitions - Analyst Blog

Will Endocyte (ECYT) Disappoint This Earnings Season? - Analyst Blog

See More ECYT News...

ECYT's Top Competitors

ECYT $5.30 (3.11%)
Current stock: ECYT
JNJ $93.35 (1.37%)
Current stock: JNJ
NVS $95.60 (0.97%)
Current stock: NVS
RHHBY $33.32 (-0.15%)
Current stock: RHHBY